NanoRepro Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

NanoRepro's earnings have been declining at an average annual rate of -20.6%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 1.1% per year.

Anahtar bilgiler

-20.6%

Kazanç büyüme oranı

-19.5%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi4.3%
Gelir büyüme oranı1.1%
Özkaynak getirisi-8.2%
Net Marj-89.8%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Cautious Investors Not Rewarding NanoRepro AG's (ETR:NN6) Performance Completely

Mar 01
Cautious Investors Not Rewarding NanoRepro AG's (ETR:NN6) Performance Completely

The Market Lifts NanoRepro AG (ETR:NN6) Shares 28% But It Can Do More

Sep 13
The Market Lifts NanoRepro AG (ETR:NN6) Shares 28% But It Can Do More

A Look At The Intrinsic Value Of NanoRepro AG (ETR:NN6)

Aug 04
A Look At The Intrinsic Value Of NanoRepro AG (ETR:NN6)

NanoRepro (ETR:NN6) Is Experiencing Growth In Returns On Capital

Apr 12
NanoRepro (ETR:NN6) Is Experiencing Growth In Returns On Capital

NanoRepro (ETR:NN6) Is Doing The Right Things To Multiply Its Share Price

Dec 15
NanoRepro (ETR:NN6) Is Doing The Right Things To Multiply Its Share Price

Robust Earnings May Not Tell The Whole Story For NanoRepro (ETR:NN6)

May 29
Robust Earnings May Not Tell The Whole Story For NanoRepro (ETR:NN6)

NanoRepro AG's (ETR:NN6) Stock Is Going Strong: Have Financials A Role To Play?

Jan 04
NanoRepro AG's (ETR:NN6) Stock Is Going Strong: Have Financials A Role To Play?

Gelir ve Gider Dağılımı

NanoRepro nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

XTRA:NN6 Gelir, gider ve kazançlar (EUR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 244-350
31 Mar 243-450
31 Dec 233-540
30 Sep 239-630
30 Jun 2314-720
31 Mar 2327-520
31 Dec 2239-420
30 Sep 2254020
30 Jun 2269420
31 Mar 221161730
31 Dec 211633030
30 Sep 211492920
30 Jun 211352720
31 Mar 21761420
31 Dec 2017210
30 Sep 2010110
30 Jun 203010
31 Mar 202-110
31 Dec 192-110
30 Sep 192-110
30 Jun 192-110
31 Mar 192-110
31 Dec 183010
30 Sep 183010
30 Jun 183-110
31 Mar 182-110
31 Dec 172-110
30 Sep 172-110
30 Jun 172010
31 Mar 172-110
31 Dec 162-110
30 Sep 161-110
30 Jun 161-110
31 Mar 161-110
31 Dec 151-100
30 Sep 151-110
30 Jun 151-100
31 Mar 151000
31 Dec 141000
30 Sep 141000
30 Jun 140000
31 Mar 141000
31 Dec 132000

Kaliteli Kazançlar: NN6 is currently unprofitable.

Büyüyen Kar Marjı: NN6 is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NN6 is unprofitable, and losses have increased over the past 5 years at a rate of 20.6% per year.

Büyüme Hızlandırma: Unable to compare NN6's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: NN6 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Özkaynak Getirisi

Yüksek ROE: NN6 has a negative Return on Equity (-8.2%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin